Hydrogen-Releasing Microrobots Show Promise for Sepsis Treatment
- Authors
- Yanzhen Song, Ruotian Zhang, Hanfeng Qin, Wenxin Xu, Jia Sun, Jiamiao Jiang, Yicheng Ye, Junbin Gao, Huaan Li, Weichang Huang, Liu Kun, Yunrui Hu, Fei Peng, Yingfeng Tu
- Journal
- Advanced Science
- Year
- 2023
- DOI
- 10.1002/advs.202303759
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Sepsis
- Body System
- Immune System
TL;DR
Scientists have created a tiny, self-propelled device that delivers antibiotics and produces hydrogen to effectively treat sepsis in mice, significantly increasing their survival rates.
Key Finding
A hydrogen-generating micromotor loaded with antibiotic achieved 87.5% survival in mice with fatal sepsis, compared to 0% survival in untreated controls and ~50% survival with either treatment alone.
Summary
Researchers created a tiny biodegradable device loaded with an antibiotic that generates hydrogen gas as it moves through the body. In mice with severe sepsis (a life-threatening infection), this device was placed in the abdominal cavity where it reacted with fluid to produce hydrogen gas, which powered its movement and delivered the antibiotic directly to infected areas. The combination of hydrogen's anti-inflammatory effects and the antibiotic's bacteria-killing power worked together to prevent organ damage and improved survival rates to 87.5% in mice that would have otherwise died.
Practical Takeaway
This is early-stage research in mice only, demonstrating a novel concept of combining hydrogen generation with antibiotic delivery for sepsis treatment. While the results are promising for future medical applications, this device is not available for human use and much more research is needed before any conclusions can be drawn about hydrogen's role in treating sepsis in people.
Abstract
Sepsis is a highly heterogeneous syndrome normally characterized by bacterial infection and dysregulated systemic inflammatory response that leads to multiple organ failure and death. Single anti-inflammation or anti-infection treatment exhibits limited survival benefit for severe cases. Here a biodegradable tobramycin-loaded magnesium micromotor (Mg-Tob motor) is successfully developed as a potential hydrogen generator and active antibiotic deliverer for synergistic therapy of sepsis. The peritoneal fluid of septic mouse provides an applicable space for Mg-water reaction. Hydrogen generated sustainably and controllably from the motor interface propels the motion to achieve active drug delivery along with attenuating hyperinflammation. The developed Mg-Tob motor demonstrates efficient protection from anti-inflammatory and antibacterial activity both in vitro and in vivo. Importantly, it prevents multiple organ failure and significantly improves the survival rate up to 87.5% in a high-grade sepsis model with no survival, whereas only about half of mice survive with the individual therapies. This micromotor displays the superior therapeutic effect of synergistic hydrogen-chemical therapy against sepsis, thus holding great promise to be an innovative and translational drug delivery system to treat sepsis or other inflammation-related diseases in the near future.